Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma
Stephanie Guyomard, Gilles Salles, Marie Coudurier, Hugues Rousset,
Bertrand Coiffier, Jacques Bienvenu, Nicole Fabien,
Hugues Rousset
Department of Internal Medicine, Centre Hospitalier Lyon-Sud, HCL, Pierre-Bénite, France
Search for more papers by this authorStephanie Guyomard, Gilles Salles, Marie Coudurier, Hugues Rousset,
Bertrand Coiffier, Jacques Bienvenu, Nicole Fabien,
Hugues Rousset
Department of Internal Medicine, Centre Hospitalier Lyon-Sud, HCL, Pierre-Bénite, France
Search for more papers by this authorNicole Fabien, Laboratoire d'Auto-Immunité, Centre Hospitalier Lyon-Sud (Hospices Civils de Lyon), Chemin du Grand Revoyet, 69495 Pierre-Bénite cedex, France. E-mail: [email protected]
Abstract
Summary. The presence of antinuclear autoantibodies (ANA) was investigated in a large cohort of patients with non-Hodgkin's lymphoma (NHL) in order to assess their frequency, specificity and prognostic relevance. ANA were analysed in 347 patients with different histological subgroups of NHL and in 213 controls using an indirect immunofluorescence technique on HEp2 cells. As the appearance of autoantibodies may be found after treatment of NHL, samples were collected at the time of diagnosis of NHL before any therapy. Sixty-six (19%) NHL patients and 12 (5·6%) patients from the control group displayed ANA. The prevalence between the two groups was found to be significantly higher in NHL patients (P < 0·0001) with a marked increased prevalence in follicular and mantle cell lymphoma subgroups. Autoantibodies directed against mitotic proteins or mitotic-associated proteins were found in 6·9% of NHL patients versus 0·5% in the control group (P < 0·001), with a significantly increased incidence in follicular and mantle cell lymphoma subgroups (P < 0·0001). Some 28% of the patients with positive ANA displayed clinical symptoms that could correspond to classical autoimmune manifestations, this frequency appearing to be higher in the marginal zone/mucosa-associated lymphoid tissue lymphoma subgroup. These data demonstrate a significant incidence of ANA before any treatment in NHL occurrence, which seems to be higher in some histological subgroups with particular ANA, such as ANA directed against mitotic proteins or mitotic-associated proteins.
REFERENCES
- Abu-Shajran, M., Buskila, D., Ehrenfeld, M., Conrad, K. & Shoenfeld, Y. (2001) Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Annals of Rheumatic Disease, 60, 433 – 441.
- Adams, B.B. & Mutasim, D.F. (2000) (2000) The diagnostic value of anti-nuclear antibody testing. International Journal of Dermatology, 39, 887 – 891.
- Ansell, S.M., Grant, C.S. & Habermann, T.M. (1999) Primary thyroid lymphoma. Seminars in Oncology, 26, 316 – 323.
- Antoine, J.C. & Honnorat, J. (2000) Anti-neuronal antibodies and central nervous system diseases. contribution to diagnosis and pathophysiology. Review of Neurology, 156, 23 – 33.
-
Aozasa, K.,
Inoue, A.,
Tajima, K.,
Miyauchi, A.,
Matsuzuka, F. &
Kuma, K. (1986) Malignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors.
Cancer, 58, 100
–
104.
10.1002/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
-
Aozasa, K.,
Ueda, T.,
Katagiri, S.,
Matsuzuka, F.,
Kuma, K. &
Yonezawa, T. (1987) Immunologic and immunohistologic analysis of 27 cases with thyroid lymphomas.
Cancer, 60, 969
–
973.
10.1002/1097-0142(19870901)60:5<969::AID-CNCR2820600509>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Asherson, R.A., Block, S., Houssiau, F.A. & Hughes, G.R. (1991) Systemic lupus erythematosus and lymphoma: association with antiphospholipid syndrome. Journal of Rheumatology, 8, 277 – 279.
- Barrios, Y., Plaza, A., Cabrera, R. & Diaz-Espada, F. (2000) Autoantibody activity of the immunoglobulin secreted by a follicular B-cell lymphoma. Acta Pathologica, Microbiologica et Immunologica, 108, 764 – 770.
- Beaufay, H., Amar Costesec, A., Feytmans, E., Thines Sempoux, D., Wibo, M., Robbi, M. & Berthet, J. (1974) Analytical study of microsomes and subcellular membranes from rat liver. I. Biochemical methods. Journal of Cell Biology, 61, 188 – 200.
- Blaes, F., Klotz, M., Huwer, H., Straub, U., Kalweit, G., Schimrigk, K. & Schafers, H.J. (2000) Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Annals of Thoracic Surgery, 69, 254 – 258.
- Borche, L., Lim, A., Binet, J.L. & Dighiero, G. (1990) Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood, 76, 562 – 569.
- Casiano, C.A., Humbel, R.L., Peebles, C., Covini, G. & Tan, E.M. (1995) Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. Journal of Autoimmunity, 84, 575 – 586.
- Chandor, S.B. (1988) Autoimmune phenomena in lymphoid malignancies. Clinical Laboratory Medicine, 8, 373 – 384.
- Chen, T.R. (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenetics and Cell Genetics, 48, 19 – 24.
- Dighiero, G. (1998) Autoimmunity and B-cell malignancies. Hematology and Cell Therapy, 40, 1 – 9.
- Disis, M.L. & Cheever, M.A. (1996) Oncogenic proteins as tumor antigens. Current Opinion in Immunology, 8, 637 – 642.
- Duhrsen, U., Augener, W., Zwingers, T. & Brittinger, G. (1987) Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. British Journal of Haematology, 67, 235 – 239.
- Fabien, N., Moreira, A., Lavergne, J.P., Reboud, J.P., Desbos, A., Perrier, H., Venot, A., Bargis, P., Vard, C., Bienvenu, J. & Monier, J.C. (1999) Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the PO, P1 and P2 proteins. Journal of Autoimmunity, 13, 103 – 110.
-
Fernandez-Madrid, F. &
Tomkiel, J. (2000) Antinuclear antibodies as potential markers of lung cancer. In: Cancer and Autoimmunity
(ed. by Y. Shoenfeld & M.E. Gershwin), pp. 151
–
158. Elsevier Science.
10.1016/B978-044450331-2/50017-5 Google Scholar
- Fleischmann, M., Celerier, P., Bernard, P., Litoux, P. & Dreno, B. (1996) Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology, 192, 50 – 55.
- Gadol, N. & Ault, K.A. (1986) Phenotypic and functional characterization of human Leu1 (CD5) B cells. Immunological Review, 93, 23 – 34.
- Granel, B., Bouabdallah, R., Serratrice, J., Swiader, L., Veit, V.V., Horschowski, N., Xerri, L., Disdier, P. & Weiller, P. (2001) Prelymphomatous presentation of T-cell non-Hodgkin lymphomas. A clinical and histopathological study of 11 cases. European Journal of Internal Medicine, 12, 57 – 59.
- Gronbaek, K., D'amore, F. & Schmidt, K. (1995) Autoimmune phenomena in non-Hodgkin's lymphoma. Leukemia and Lymphoma, 18, 311 – 316.
- Gronbaek, K., Straten, P.T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M.K., Hansen, N.E., Zeuthen, J., Hou Jensen, K. & Guldberg, P. (1998) Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood, 92, 3018 – 3024.
- Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361 – 1392.
- Hollingsworth, P.N., Dawkins, R.I. & Peter, J.B. (1996) Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution. Clinical and Diagnostic Laboratory Immunology, 3, 374 – 377.
- Huminer, D., Tomer, Y., Pitlick, S. & Shoenfeld, Y. (1990) Autoantibodies in cancer patients: are they tumor related or age related. Autoimmunity, 5, 232 – 233.
- Jonsson, V., Wiik, A., Hou-Jensen, K., Christiansen, M., Ryder, L.P., Madsen, H.O., Geisler, C., Hansen, M.M., Thomsen, K., Vorstrup, S. & Svejgaard, A. (1999) Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. Journal of Internal Medicine, 245, 277 – 286.
- Levine, A.M. (1994) Lymphoma complicating immunodeficiency disorders. Annals of Oncology, 5, 29 – 35.
- McCurley, T.L., Collins, R.D., Ball, E. & Collins, R.D. (1990) Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome. a clinical and immunopathologic study. Human Pathology, 21, 482 – 492.
- Mariette, X. (1999) Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis. Leukemia and Lymphoma, 33, 93 – 99.
- Mellemkjaer, L., Andersen, V., Linet, M.S., Grideley, G., Hoover, R. & Olsen, J.H. (1997) Non Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematous. Arthritis and Rheumatism, 40, 761 – 768.
- Montenarh, M., Harlozinska, A., Bar, J.K., Kartarius, S., Gunther, J. & Sedlaczek, P. (1998) p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer. International Journal of Oncology, 13, 605 – 610.
- Ortiz-Hidalgo, C. & Wright, T.D. (1992) .H. The morphological spectrum of monocytoid B-cell lymphoma and its relationship to lymphomas of mucosa-associated lymphoid tissue. Histopathology, 21, 555 – 561.
- Pasquinelli, C., Bhavani, K. & Chisari, F.V. (1992) Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Research, 52, 2823 – 2829.
- Penin, F., Godinot, C., Comte, J. & Gautheron, D.C. (1982) Vesicular preparation of a highly coupled ATPase-ATP synthase complex from pig heart mitochondria. Biochimica et Biophysica Acta, 679, 198 – 209.
- Peterson, S.R., Talpur, R. & Duvic, M. (1998) Antinuclear antibody seropositivity in patients with cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology, 39, 434 – 438.
- Polliack, A. & Lugassy, G. (1992) Autoimmunity and auto–immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia, 6, 152 – 154.
- Rattner, J.B., Rao, A., Fritzler, M.J., Valencia, D.W. & Yen, T.J. (1993) CENP-F is a 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cellular Motility Cytoskeleton, 26, 214 – 226.
- Rattner, J.B., Rees, J., Whitehead, C.M., Casiano, C.A., Tan, E.M., Humbel, R.L., Conrad, K. & Fritzler, M.J. (1997) High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clinical Investigation of Medicine, 20, 308 – 319.
- Rattner, J.B., Mack, G.J. & Fritzler, M.J. (1998) Autoantibodies to components of the mitotic apparatus. Molecular Biology Reports, 25, 143 – 155.
- Reeves, W.H. (2001) Tumor immunity and autoimmunity: a case of Dr Jekyll and Mr Hyde. Clinical Immunology, 100, 129 – 133.
- Rodenburg, R.J., Raats, J.M., Pruijn, G.J. & Van Venrooij, W.J. (2000) Cell death: a trigger of autoimmunity. Bioassays, 22, 627 – 636.
- Rovere, P., Fazzini, F., Sabbadini, M.G. & Manfredi, A.A. (2000) Apoptosis and systemic autoimmunity: the dendritic cell connection. European Journal of Histochemistry, 44, 229 – 236.
- Rustin, M.H., Isenberg, D.A., Griffiths, M.H. & Gilkes, J.J. (1988) Sjogren's syndrome and pleomorphic T-cell lymphoma presenting with skin involvement. Journal of the Royal Society of Medicine, 81, 47 – 49.
- Sallah, S., Sigounas, G., Vos, P., Wan, J.Y. & Nguyen, N.P. (2000) Autoimmune lymphocytic anemia in patients with non Hodgkin's lymphoma: characteristics and significance. Annals of Oncology, 11, 1571 – 1577.
- Sato, S., Fujimoto, M., Ihn, H. & Takehara, K. (1994) Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology, 189, 23 – 26.
- Stockert, E., Jager, E., Chen, Y.T., Scanlan, M.J., Gout, I., Karbach, J., Arand, M., Knuth, A. & Old, L.J. (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. Journal of Experimental Medicine, 187, 1349 – 1354.
- Swissa, M., Cohen, Y. & Schoenfeld, Y. (1992) Autoantibodies in the sera of patients with lymphoma. Leukemia and Lymphoma, 7, 117 – 122.
- Syrigos, K.N., Charalambopoulos, A., Pliarchopoulou, K., Varsamidakis, N., Machairas, A. & Mandrekas, D . (2000) The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma. Anticancer Research, 20, 4351 – 4353.
-
Tamura, K.,
Shimaoka, K. &
Friedman, M. (1981) Thyroid abnormalities associated with treatment of malignant lymphoma.
Cancer, 47, 2704
–
2711.
10.1002/1097-0142(19810601)47:11<2704::AID-CNCR2820471129>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- Timuragaoglu, A., Dumain, A., Ongut, G., Saka, O. & Karadogan, I. (2000) The significance of autoantibodies in non-Hodgkin's lymphoma. Leukemia and Lymphoma, 40, 119 – 122.
- Tiplady, C.W., Hamilton, P.J. & Galloway, M.J. (2000) Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine. Clinical Laboratory Haematology, 22, 163 – 165.
- Torchilin, V.P., Iakoubov, L.Z. & Estrov, Z. (2001) Antinuclear autoantibodies as potential antineoplastic agents. Trends in Immunology, 22, 424 – 427.
- Tuffanelli, D.L., McKeon, F., Kleinsmith, D.M., Burnham, T.K. & Kirschner, M. (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Archives of Dermatology, 119, 560 – 566.
- Tursi, A. & Gasbarrini, G. (1999) Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. Journal of Clinical Gastroenterology, 29, 133 – 137.
- Wasserman, J., Glas, U. & Blomgren, H. (1975) Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clinical and Experimental Immunology, 19, 417 – 422.
- Winter, S.F., Minna, J.D., Johnson, B.E., Takahashi, T., Gazdar, A.F. & Carbone, D.P. (1992) Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Research, 52, 4168 – 4174.
- Xavier, R.M., Yamauchi, Y., Nakamura, M., Tanigawa, Y., Ishikura, H., Tsunematsu, T. & Kobayashi, S. (1995) Antinuclear antibodies in healthy aging people: a prospective study. Mechanisms of Ageing and Development, 78, 145 – 154.
- Youinou, P., Mackenzie, L.E., Lamour, A., Magged, R.A. & Lydyard, P.M. (1993) Human CD-positive b cells in lymphoid malignancy and connective tissue diseases. European Journal of Clinical Investigation, 23, 139 – 150.
- Zhang, J.Y., Chan, E.K.L., Peng, X.X., Lu, M., Wang, X., Mueller, F. & Tan, E.M. (2001a) Autoimmune responses to mRNA binding proteins p62 and Kox in diverse malignancies. Clinical Immunology, 100, 149 – 156.
- Zhang, J.Y., Zhu, W., Imai, H., Kiyosawa, K., Chan, E.K. & Tan, E.M. (2001b) De novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clinical and Experimental Immunology, 125, 3 – 9.
Citing Literature
